Abstract
Understanding the stability of the shrimp allergen tropomyosin (TM) in shrimp powder at different temperatures is necessary to develop shrimp oral immunotherapy (SOIT). We evaluated the shrimp TM stability for different storage times for utilization in a SOIT clinical trial and determined the specific IgE (sIgE) binding capacity of raw and cooked shrimp allergen extracts.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
